Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Revenue

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Net Sales ₹263 Cr₹224 Cr₹220 Cr₹18,482,242 Cr₹184 Cr

What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?

The latest Revenue ratio of SYNCOM FORMULATIONS (INDIA) is ₹263 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹263 Cr
Mar2024₹224 Cr
Mar2023₹220 Cr
Mar2022₹18,482,242 Cr
Mar2017₹184 Cr

How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?

Years Revenue % Change
Mar2025 ₹263 Cr
17.45
Mar2024 ₹224 Cr
2.09
Mar2023 ₹220 Cr
-100.00
Mar2022 ₹18,482,242 Cr
10,050,222.98
Mar2017 ₹184 Cr -

Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,379.0 Cr -6.1% 6.4% -32.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,349.0 Cr -3% -1.9% 7.5% Stock Analytics
DIVIS LABORATORIES ₹174,543.0 Cr -3.3% -0.7% -1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,884.0 Cr -3.8% 2.8% 36.4% Stock Analytics
CIPLA ₹111,077.0 Cr -3% 3% -6.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,388.0 Cr -4.3% -2% 2.5% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-6.1%

6.4%

-32.6%

SENSEX

-2.2%

-3.3%

-8.8%


You may also like the below Video Courses